Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Service Development: Assessing Non-Attendance Rates in Outpatient Clinics

This study has been completed.
Sponsor:
Information provided by:
Imperial College London
ClinicalTrials.gov Identifier:
NCT00129649
First received: August 11, 2005
Last updated: September 8, 2005
Last verified: August 2005
  Purpose

Many studies have shown a high non-attendance rate in hospital outpatient clinics. The investigators have found a non-attendance rate of 25% in their asthma clinics and would like to investigate whether a reminder phone call will improve attendance rates. Patients will be randomised into two groups; one group will receive a reminder phone call one week prior to their hospital consultation and the other group will be managed in the standard manner (i.e. no reminder of any sort). The phone calls will be carried out on a Friday afternoon by a respiratory nurse specialist and a research officer for two asthma clinics based on a Wednesday morning and a Thursday afternoon.


Condition Intervention
Asthma
Sleep Apnea Syndromes
Tuberculosis
COPD
Behavioral: Telephone reminder call

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Service Development: Assessing Non-Attendance Rates in Outpatient Clinics

Resource links provided by NLM:


Further study details as provided by Imperial College London:

Primary Outcome Measures:
  • Attendance rates at respiratory outpatient clinics

Estimated Enrollment: 500
Study Start Date: May 2005
Estimated Study Completion Date: May 2005
Detailed Description:

Many studies have shown a high non-attendance rate in hospital outpatient clinics. The investigators have found a non-attendance rate of 25% in their asthma clinics and would like to investigate whether a reminder phone call will improve attendance rates. Patients will be randomised into two groups; one group will receive a reminder phone call one week prior to their hospital consultation and the other group will be managed in the standard manner (i.e. no reminder of any sort). The phone calls will be carried out on a Friday afternoon by a respiratory nurse specialist and a research officer for two asthma clinics based on a Wednesday morning and a Thursday afternoon.

To have an 80% chance of detecting a 10% reduction in non-attendance rates (at 5%) 500 patients are required for this study. The rate of non-attendance will be monitored for all the patients in both groups and some demographic information will be recorded for each patient(age, sex, diagnosis and home postcode).

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients with appointments booked for 2 respiratory outpatient clinics
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00129649

Locations
United Kingdom
NHLI Imperial College
London, United Kingdom, W6 8RF
Sponsors and Collaborators
Imperial College London
Investigators
Principal Investigator: Martyn R Partridge, MD FRCP Imperial College London
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00129649     History of Changes
Other Study ID Numbers: NHLICX3806
Study First Received: August 11, 2005
Last Updated: September 8, 2005
Health Authority: United Kingdom: Research Ethics Committee

Additional relevant MeSH terms:
Sleep Apnea Syndromes
Tuberculosis
Actinomycetales Infections
Apnea
Bacterial Infections
Dyssomnias
Gram-Positive Bacterial Infections
Mycobacterium Infections
Nervous System Diseases
Respiration Disorders
Respiratory Tract Diseases
Sleep Disorders
Sleep Disorders, Intrinsic

ClinicalTrials.gov processed this record on November 24, 2014